BioCision, LLC Announces Industry’s First Automated Biospecimen Thawing System

SAN RAFAEL, Calif.--(BUSINESS WIRE)--BioCision, LLC, a leader in advanced products to improve biospecimen and biologics handling and standardization, today announced the availability of ThawSTAR™ automated sample thawing system, a breakthrough technology that addresses the “last mile” in the cryopreservation process. Utilizing the patent-pending STAR™ sensing technology, ThawSTAR system tailors the thaw cycle to the specific characteristics of each frozen sample.

Consistent with BioCision’s objective to standardize important workflows, the ThawSTAR technology platform represents another industry first and sets a new standard for how cells and cell-based therapies are thawed. The ThawSTAR technology integrates multiple detection algorithms to ensure uniform thermal profiles and reproducible recovery of the frozen contents, eliminating the subjectivity found in conventional thaw methods that rely on human interpretation, such as swirling frozen vials in water baths, rolling vials between hands and other crude methods. Each of these outdated methods carries a high level of risk for temperature variation and sample contamination, important considerations in the preparation of cells, including cell therapy drugs.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC